EUVIMEDEUVIMED entdecken
VergleichsstudieEvaluationsstudie

Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease

Elizabeth L Lewandrowski, Sarah E Turbett iD, Lise E Nigrovic, Erik H Klontz, John A Branda

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae229 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Elizabeth L Lewandrowski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Lyme Disease, Serologic Tests, Immunoglobulin G, Immunoglobulin M. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Zeus Scientific.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Modified 2-tiered testing (MTTT) for Lyme disease utilizes automatable, high throughput immunoassays (AHTIs) in both tiers without involving western immunoblots, offering performance and practical advantages over standard 2-tiered testing (STTT; first-tier AHTI followed by immunoglobulin M (IgM) and immunoglobulin G (IgG) western immunoblots). For MTTT, Centers for Disease Control and Prevention recommends using AHTI test kits that have been cleared by Food and Drug Administration (FDA) specifically for this intended use. We evaluated performance of FDA-cleared MTTT commercial test kits from 3 manufacturers by comparing with STTT results.

Methods

We performed MTTT (total antibody AHTI with reflex to separate IgM and IgG AHTIs) using test kits from Diasorin, Gold Standard Diagnostics (GSD), and Zeus Scientific on 382 excess serum samples submitted to the clinical laboratory for routine Lyme disease serologic testing in July 2018, measuring agreement between MTTT and STTT using the κ statistic.

Results

Overall agreement with STTT was 0.87 (95% confidence interval [CI], .77–.97) using Diasorin assays (almost perfect agreement), 0.80 (95% CI, .68–.93) using GSD assays (substantial agreement) and 0.79 (95% CI, .68–.90) using Zeus assays (substantial agreement). For detection of IgM reactivity, agreement between MTTT and STTT was 0.70 (.51–.90; substantial), 0.63 (95% CI, .44–.82; substantial) and 0.56 (95% CI, .38–.73; moderate), respectively. For detection of IgG reactivity, MTTT/STTT agreement was 0.73 (95% CI,.58–.88), 0.78 (95% CI, .62–.94), and 0.75 (95% CI, .60–.90), respectively (substantial agreement in all cases).

Conclusions

MTTT results obtained using commercial test kits from 3 different manufacturers had substantial to almost perfect agreement with STTT results overall and moderate to substantial agreement for IgM and IgG detection independently. Commercial MTTT tests can be used broadly for the diagnosis of Lyme disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lyme DiseaseSerologic TestsImmunoglobulin GImmunoglobulin MReagent Kits, DiagnosticAntibodies, BacterialHumansAlgorithmsSensitivity and SpecificityImmunoassayUnited StatesBorrelia burgdorferiMiddle AgedAdultFemale

Stichwörter der Autor:innen

Borrelia burgdorferiLymeantibodydiagnosisserology

Substanzen

Immunoglobulin GImmunoglobulin MReagent Kits, DiagnosticAntibodies, Bacterial

Autor:innen und Institutionen

  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Division of Emergency Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Sarah E Turbett

Förderung

  • Zeus Scientific

Zitieren

APA

Lewandrowski, E. L., Turbett, S. E., Nigrovic, L. E., Klontz, E. H., & Branda, J. A. (2024). Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae229

Vancouver

Lewandrowski EL, Turbett SE, Nigrovic LE, Klontz EH, Branda JA. Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae229

BibTeX
@article{Lewandrowski2024,
  author = {Lewandrowski, Elizabeth L and Turbett, Sarah E and Nigrovic, Lise E and Klontz, Erik H and Branda, John A},
  title = {Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae229}
}
Kostenlos starten →